Calton & Associates’s Ambev ABEV Stock Holding History

Calton & Associates’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,155	Closed	-$68K	–	348
2017 Q4	$68K	Buy	+10,155	New	+$65K	0.02%	579

Other funds holding ABEV

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MNG

Manning & Napier Group Fairport, New York $8.76B AUM 23.27% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Calton & Associates's ABEV Position: Q1 2018 in Review

Calton & Associates sold out of Ambev (ABEV) in Q1 2018, closing a stake of 10,155 shares — an estimated $68K sold.

Calton & Associates first reported a position in ABEV in Q4 2017 and held it in 1 quarter. The position peaked at $68K in Q4 2017. 334 funds tracked by Wall St. Rank hold ABEV as of Q1 2018.

Calton & Associates reported no remaining Ambev position as of Q1 2018 after selling out during the quarter.
Calton & Associates sold 10,155 Ambev shares in Q1 2018, an estimated $68K.
Calton & Associates first reported a position in Ambev in Q4 2017 and held it in 1 quarter.
Calton & Associates's Ambev position peaked at $68K in Q4 2017.
334 funds tracked by Wall St. Rank held Ambev as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.